127 related articles for article (PubMed ID: 34269109)
1. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.
Dubrovskyi O; Hasten E; Dudek SM; Flavin MT; Chan LL
SLAS Discov; 2021 Oct; 26(9):1079-1090. PubMed ID: 34269109
[TBL] [Abstract][Full Text] [Related]
2. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
[TBL] [Abstract][Full Text] [Related]
3. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID-19 pandemic.
Schmid B; Kranke P; Lucas R; Meybohm P; Zwissler B; Frank S
Trials; 2022 Apr; 23(1):252. PubMed ID: 35379296
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
5. Metformin in acute respiratory distress syndrome: An opinion.
Uddin MA; Akhter MS; Kubra KT; Siejka A; Barabutis N
Exp Gerontol; 2021 Mar; 145():111197. PubMed ID: 33310152
[TBL] [Abstract][Full Text] [Related]
6. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.
Kushimoto S; Taira Y; Kitazawa Y; Okuchi K; Sakamoto T; Ishikura H; Endo T; Yamanouchi S; Tagami T; Yamaguchi J; Yoshikawa K; Sugita M; Kase Y; Kanemura T; Takahashi H; Kuroki Y; Izumino H; Rinka H; Seo R; Takatori M; Kaneko T; Nakamura T; Irahara T; Saito N; Watanabe A;
Crit Care; 2012 Dec; 16(6):R232. PubMed ID: 23232188
[TBL] [Abstract][Full Text] [Related]
7. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Atmowihardjo L; Schippers JR; Bartelink IH; Bet PM; van Rein N; Purdy K; Cavalla D; Comberiati V; McElroy A; Snape SD; Bogaard HJ; Heunks L; Juffermans N; Schultz M; Tuinman PR; Bos LDJ; Aman J
Trials; 2022 Feb; 23(1):158. PubMed ID: 35172891
[TBL] [Abstract][Full Text] [Related]
8. Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.
Rasch S; Schmidle P; Sancak S; Herner A; Huberle C; Schulz D; Mayr U; Schneider J; Spinner CD; Geisler F; Schmid RM; Lahmer T; Huber W
Sci Rep; 2021 Jun; 11(1):11524. PubMed ID: 34075155
[TBL] [Abstract][Full Text] [Related]
9. Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS-a randomized, placebo-controlled, double-blind trial.
Schmid B; Kredel M; Ullrich R; Krenn K; Lucas R; Markstaller K; Fischer B; Kranke P; Meybohm P; Zwißler B; Frank S;
Trials; 2021 Sep; 22(1):643. PubMed ID: 34544463
[TBL] [Abstract][Full Text] [Related]
10. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
11. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
12. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
Han M; Pandey D
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):300-308. PubMed ID: 34003736
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Damage in Acute Respiratory Distress Syndrome.
Vassiliou AG; Kotanidou A; Dimopoulou I; Orfanos SE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233715
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians.
Batah SS; Fabro AT
Respir Med; 2021 Jan; 176():106239. PubMed ID: 33246294
[TBL] [Abstract][Full Text] [Related]
16. Application of POCUS in patients with COVID-19 for acute respiratory distress syndrome management: a narrative review.
Gao X; Zou X; Li R; Shu H; Yu Y; Yang X; Shang Y
BMC Pulm Med; 2022 Feb; 22(1):52. PubMed ID: 35123448
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry.
Rosen O; Chan LL; Abiona OM; Gough P; Wang L; Shi W; Zhang Y; Wang N; Kong WP; McLellan JS; Graham BS; Corbett KS
J Virol Methods; 2019 Mar; 265():77-83. PubMed ID: 30468747
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
19. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
